概括
尿液分析中药物检测的准确性是惊人的低. 两个"批准"的实验室未能在超过一半的样本中正确识别所有药物,突出了改善实验室标准和对测试错误性的认识的需要.
科学领域:
- 临床化学 临床化学
- 法医毒理学 法医毒理学
- 实验室医学 实验室医学
背景情况:
- 尿液药物检测是临床和法医环境中的关键工具.
- 这些测试的准确性和可靠性对于患者护理和法律诉讼至关重要.
- 现有的实验室审批流程可能无法充分确保一致的性能.
研究的目的:
- 通过尿样评估药物识别在尿样中的准确性.
- 经过批准批准的批准.
- 实验室. 实验室. 在实验室.
- 评估在常规药物查中虚假阳性和虚假阴性结果的比率.
- 建议改善尿液药物检测中的实验室质量保证.
主要方法:
- 准备的尿样,含有五种向药物的不同数量和度.
- 将这些标本提交给两个不同的标本.
- 经过批准批准的批准.
- 临床实验室用于分析.
- 将实验室结果与提交的样本已知的成分进行比较.
主要成果:
- 实验室1只在46.9%的样本中正确识别了所有药物,没有假阳性.
- 实验室2仅在13.8%的样本中实现了这种准确度.
- 考虑到一些差异,准确性分别提高到53.8%和49.4%,表明了显著的变化.
结论:
- 当前的尿液药物检测方法和方法.
- 经过批准批准的批准.
- 实验室表现出显著的错误性.
- 治疗人员必须了解这些测试限制.
- 建议包括强制性实验室许可和通过能力测试进行基于绩效的许可维护.
相关概念视频
Drug Elimination by Renal Route: Tubular Reabsorption
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
Factors Affecting Renal Clearance: Renal Impairment
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...


